LLS’s Fairness in Entry Analysis Program Awards 4 New Grants to Researchers Finding out the Relationship Between Well being Insurance coverage and Entry to Care and Interventions to Improve Therapeutic Scientific Trial Enrollment and Variety
RYE BROOK, N.Y., July 10, 2024 /PRNewswire/ — The Leukemia & Lymphoma Society’s (LLS) Fairness in Entry Analysis Program has collectively awarded practically $6.5 million to well being companies researchers working to uncover and finally tackle the social, financial, and environmental disadvantages that stand in the way in which of blood most cancers sufferers and survivors accessing the high-quality therapy and care they want all through their lives.
LLS expanded Fairness in Entry in 2024 by releasing two Requests for Proposals, which sought proposals that might generate proof to extend understanding of the affect of medical health insurance on entry to care and that might implement and consider interventions designed to enhance therapeutic scientific trial enrollment, notably amongst underrepresented teams.
Findings from these research will allow LLS to attract on a higher physique of actionable proof to tell its personal and others’ efforts to foster significant change in healthcare coverage and develop packages that tangibly enhance the lives of blood most cancers sufferers and survivors.
“Whereas most cancers can affect anybody, the unlucky actuality is that equitable entry to high-quality, reasonably priced therapy and care is out of attain for a lot of, and no different group is funding analysis particularly on fairness in entry for blood most cancers sufferers and survivors,” stated Eric Cooks, PhD, Senior Director, Fairness in Entry Analysis Program at LLS. “As a number one most cancers nonprofit, LLS is dedicated to reworking lives by way of our holistic strategy throughout analysis, affected person help, and advocacy which incorporates advancing well being fairness and eliminating well being disparities. This analysis is a primary step towards serving to all sufferers and survivors obtain significant entry to the therapy and care they want after they want it.”
LLS’s Fairness in Entry Analysis Program 2024 Cohort
This system’s third cohort has acquired practically $6.5 million in mixed funding and includes the excellent researchers beneath named in alphabetical order of principal investigator adopted by co-investigators for every examine:
- Carma Bylund, PhD, and Stephanie Staras, PhD, MPH of the College of Florida, will give attention to the implementation of group oncology methods to advertise scientific trial enrollment. The primary intervention, Enhanced Connection, will give attention to strengthening the connection between group oncologists and trial principal investigators to finally scale back obstacles to referral. The second intervention, Enhanced Communication, will embody interactive on-line coaching designed to boost group oncologist suppliers’ data and attitudes about trials and their means to debate scientific trials with their sufferers. This examine goals to offer proof for most cancers facilities to combine these practices into their normal analysis operations and to help the continued coaching of group oncologists.
- Raymond Mailhot, MD, MPH, and Erin Mobley, PhD, MPH of the College of Florida, will leverage a longitudinal database of digital well being information (EHR), administrative claims, and tumor registry knowledge to look at variations within the receipt and high quality of Hodgkin lymphoma therapy and survivorship care by insurance coverage sort. This examine can even characterize the decision-making experiences of sufferers from racial/ethnic minoritized teams by insurance coverage sort. Findings will inform the event of tailor-made, customized approaches to Hodgkin lymphoma therapy and survivorship care and advocacy for increasing Medicaid protection.
- Shazia Nakhoda, MD, Linda Fleisher, PhD, MPH, and Zachary Frosch, MD, MS, of Fox Chase Most cancers Middle, will perform a multi-level intervention to deal with disparities in scientific trial enrollment amongst traditionally underrepresented teams (e.g., racial/ethnic minoritized teams, older adults). This examine will implement a skill-based didactic course for suppliers to enhance the standard of communication round structural racism, distrust, implicit biases, and scientific trial counseling. This examine can even administer a culturally competent, specialised scientific trials nurse navigation (CTNN) program that connects sufferers to instructional sources round scientific trials and standardizes pre-screening for brand spanking new sufferers earlier than the preliminary clinic appointment. Findings will present proof of the effectiveness of a skill-based communication coaching that empowers suppliers to navigate discussions on scientific trials extra overtly and successfully and a devoted CTNN program that implements early pre-screening for eligibility and validated affected person schooling instruments on trial accrual.
- Anushree Vichare, PhD, MBBS, Clese Erikson, MPAff, and Qian “Eric” Luo, PhD of George Washington College, will use national-level Medicaid claims knowledge over eight years (2016-2023) linked to healthcare utilization info to look at telehealth provision by hematology oncologists, with a give attention to figuring out whether or not there are variations in telehealth uptake amongst susceptible populations resembling racial/ethnic minoritized teams and people dwelling in rural areas. The examine can even look at how latest legislative adjustments in telehealth protection and Medicaid funds affect telehealth entry. By together with sufferers coated by Medicaid, the findings will present first-known estimates on patterns of telehealth utilization by these sufferers and inform methods to enhance telehealth entry by way of coverage reforms.
Findings from these research might finally result in higher well being outcomes by figuring out steps healthcare techniques, suppliers, insurers, and policymakers can take to extend equitable entry to high quality and reasonably priced blood most cancers therapy (together with therapy in a scientific trial). LLS will attempt to rework the findings and associated suggestions into state and federal coverage proposals that its Workplace of Public Coverage will work to implement.
“LLS continues to construct on the success of this system’s first two teams of grant recipients,” stated Cooks. “We have been in a position to practically double the award whole from final 12 months, due to the generosity of our donors.”
LLS proudly and gratefully acknowledges Royalty Pharma and AstraZeneca for his or her help of the Fairness in Entry Analysis Program and different initiatives centered on lowering healthcare disparities in blood most cancers care and therapy.
For extra info or to rearrange an interview, please contact: [email protected].
About The Leukemia & Lymphoma Society (LLS)
The Leukemia & Lymphoma Society® (LLS) is the worldwide chief within the struggle in opposition to blood most cancers. The LLS mission: Treatment leukemia, lymphoma, Hodgkin’s illness, and myeloma, and enhance the standard of lifetime of sufferers and their households. LLS funds lifesaving blood most cancers analysis all over the world, supplies free info and help companies, and is the voice for all blood most cancers sufferers looking for entry to high quality, reasonably priced, coordinated care.
Based in 1949 and headquartered in Rye Brook, NY, LLS has areas all through the USA and Canada. To be taught extra, go to www.LLS.org. Sufferers ought to contact the Data Useful resource Middle at (800) 955-4572, Monday by way of Friday, 9 a.m. to 9 p.m. ET.
For extra info, go to lls.org/lls-newsnetwork. Observe us on Fb, X, Instagram, LinkedIn and TikTok.
SOURCE The Leukemia & Lymphoma Society (LLS)
